Skip to main content
RGEN logo

RGEN · Repligen Corp · Webcasts, Transcripts & Audio

Track RGEN — free
Market Cap
$10.73B
Shares
63.92M
Volume · Nov 13 510.17K Avg daily vol (3M) 1.19M

Repligen Corp Webcasts

Earnings calls, investor updates, investor days and conferences for Repligen Corp (RGEN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-11-18
Repligen Corp (RGEN) November 18, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-10-27
Repligen Corp (RGEN) Q3 2026 Earnings Call Transcript
Confident tone Diversified product franchise performance BioLife acquisition and integration Filtration headwinds and deferred demand
Revenue
$209.31M
▲ 10.9% YoY
Diluted EPS
$-0.68
▼ 361.5% YoY
Gross margin
53.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-09
Repligen Corp (RGEN) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-28
Repligen Corp (RGEN) Q2 2026 Earnings Call Transcript
Confident tone Protein franchise growth BioLife acquisition (cell therapy) Analytics franchise momentum
Revenue
$204.13M
▲ 11.9% YoY
Diluted EPS
$0.09
▼ 65.4% YoY
Gross margin
53.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-07-22
Repligen Corp (RGEN) July 22, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Repligen Corp (RGEN) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-12
Repligen Corp (RGEN) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Repligen Corp (RGEN) Q1 2026 Earnings Call Transcript
Confident tone Analytics Franchise Growth Margin Expansion / Transformation Office Polymem Divestiture
Revenue
$194.25M
▲ 14.8% YoY
Diluted EPS
$0.15
▲ 50% YoY
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-10
Repligen Corp (RGEN) March 10, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-24
Repligen Corp (RGEN) Q4 2025 Earnings Call Transcript
Confident tone Capital equipment and CapEx demand Services growth opportunity End markets and geographies
Revenue
$197.91M*
▲ 18.1% YoY
Gross margin
51.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Repligen Corp (RGEN) Q3 2025 Earnings Call Transcript
Confident tone Franchise Performance End Market and Geographic Strength New Modalities
Revenue
$188.81M
▲ 21.9% YoY
Diluted EPS
$0.26
Gross margin
53.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
Repligen Corp (RGEN) Q2 2025 Earnings Call Transcript
Confident tone New Modalities / Gene Therapy Headwind China and APAC Regional Outlook Margin and Operating Leverage
Revenue
$182.37M
▲ 14.8% YoY
Diluted EPS
$0.26
▲ 160% YoY
Gross margin
51.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Repligen Corp (RGEN) Q1 2025 Earnings Call Transcript
Confident tone Orders momentum Strategic initiatives and M&A Customer diversification and geographic exposure
Revenue
$169.17M
▲ 10.4% YoY
Diluted EPS
$0.10
▲ 66.7% YoY
Gross margin
54.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-20
Repligen Corp (RGEN) Q4 2024 Earnings Call Transcript
Confident tone Revenue and orders momentum CDMO and equipment recovery Hardware platform wins
Revenue
$167.55M*
▲ 0.6% YoY
Gross margin
23.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Repligen Corp (RGEN) Q3 2024 Earnings Call Transcript
Confident tone Orders and backlog momentum Regional performance and China headwind CDMO recovery
Revenue
$154.87M
▲ 9.7% YoY
Diluted EPS
$-0.01
▼ 103.3% YoY
Gross margin
50.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-30
Repligen Corp (RGEN) Q2 2024 Earnings Call Transcript
Positive tone 2024 guidance and FX CDMO order recovery China demand weakness
Revenue
$158.84M
▼ 0.2% YoY
Diluted EPS
$0.10
▼ 71.4% YoY
Gross margin
51.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
Repligen Corp (RGEN) Q1 2024 Earnings Call Transcript
Positive tone Order trends and book-to-bill Filtration franchise strength Proteins / affinity ligand headwind
Revenue
$153.18M
▼ 7.4% YoY
Diluted EPS
$0.06
▼ 77.8% YoY
Gross margin
50.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-21
Repligen Corp (RGEN) Q4 2023 Earnings Call Transcript
Positive tone M&A / Metenova Integration Market Recovery Indicators China Deterioration
Revenue
$166.62M*
▼ 10.8% YoY
Gross margin
47.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-31
Repligen Corp (RGEN) Q3 2023 Earnings Call Transcript
Revenue
$141.19M
▼ 29.7% YoY
Diluted EPS
$0.30
▼ 57.7% YoY
Gross margin
25.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Repligen Corp (RGEN) Q2 2023 Earnings Call Transcript
Revenue
$159.17M
▼ 23.3% YoY
Diluted EPS
$0.35
▼ 60.2% YoY
Gross margin
50.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Repligen Corp (RGEN) Q1 2023 Earnings Call Transcript
Revenue
$165.38M
▼ 19.9% YoY
Diluted EPS
$0.27
▼ 66.7% YoY
Gross margin
50.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
Repligen Corp (RGEN) Q4 2022 Earnings Call Transcript
Revenue
$186.76M*
▲ 0.1% YoY
Gross margin
51.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Repligen Corp (RGEN) Q3 2022 Earnings Call Transcript
Revenue
$200.74M
▲ 12.6% YoY
Diluted EPS
$0.71
▲ 22.4% YoY
Gross margin
56.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Repligen Corp (RGEN) Q2 2022 Earnings Call Transcript
Revenue
$207.63M
▲ 27.4% YoY
Diluted EPS
$0.88
▲ 37.5% YoY
Gross margin
58.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-27
Repligen Corp (RGEN) Q1 2022 Earnings Call Transcript
Revenue
$206.40M
▲ 44.5% YoY
Diluted EPS
$0.81
▲ 55.8% YoY
Gross margin
60.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
Repligen Corp (RGEN) Q4 2021 Earnings Call Transcript
Revenue
$186.52M*
▲ 71.7% YoY
Gross margin
56.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Repligen Corp (RGEN) Q3 2021 Earnings Call Transcript
Revenue
$178.22M
▲ 89.5% YoY
Diluted EPS
$0.58
▲ 114.8% YoY
Gross margin
57.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-27
Repligen Corp (RGEN) Q2 2021 Earnings Call Transcript
Revenue
$162.96M
▲ 86.3% YoY
Diluted EPS
$0.64
▲ 113.3% YoY
Gross margin
62.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Repligen Corp (RGEN) Q1 2021 Earnings Call Transcript
Revenue
$142.84M
▲ 87.7% YoY
Diluted EPS
$0.52
▲ 188.9% YoY
Gross margin
58.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Repligen Corp (RGEN) Q4 2020 Earnings Call Transcript
Revenue
$108.65M
▲ 56.4% YoY
Diluted EPS
$0.36
▲ 414.3% YoY
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Repligen Corp (RGEN) Q3 2020 Earnings Call Transcript
Revenue
$94.06M
▲ 35.4% YoY
Diluted EPS
$0.27
▲ 800% YoY
Gross margin
57.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Repligen Corp (RGEN) Q2 2020 Earnings Call Transcript
Revenue
$87.46M
▲ 23.7% YoY
Diluted EPS
$0.30
▲ 76.5% YoY
Gross margin
57.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Repligen Corp (RGEN) Q1 2020 Earnings Call Transcript
Revenue
$76.09M
▲ 25.5% YoY
Diluted EPS
$0.18
▲ 5.9% YoY
Gross margin
58.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-20
Repligen Corp (RGEN) Q4 2019 Earnings Call
Revenue
$69.47M
▲ 33.8% YoY
Diluted EPS
$0.07
▼ 41.7% YoY
Gross margin
56.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–34 of 34 webcasts
Key facts CIK 730272 CUSIP 759916109 13F (30d) 399 filings 365 filers Visit website Investor relations